Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging

Journal of Controlled Release

Volumn 169, Issue 3, 2013, Pages 239-245

  Ye, Mingzhou ^a   Qian, Yue ^b   Tang, Jianbin ^a   Hu, Hongjie ^b   Sui, Meihua ^a   Shen, Youqing ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Biodegradability; Contrast agent; Dendrimer; MRI; Tumor imaging

Indexed keywords

BIODEGRADABILITY; DENDRIMERS; DICHLOROACETIC ACID; TUMORS;

CONTRAST AGENT; CONTRAST ENHANCEMENT; CONTRAST-ENHANCED; IMAGING CONTRAST; LONG-TERM RETENTION; MRI CONTRAST AGENTS; POLYESTER DENDRIMERS; TUMOR IMAGING;

MAGNETIC RESONANCE IMAGING;

CHELATE; CONTRAST MEDIUM; DENDRIMER; DENDRITIC CONTRAST AGENT; FOLATE RECEPTOR; FOLIC ACID; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; PENTETIC ACID; POLYESTER; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG RETENTION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 84885171754     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.01.034     Document Type: Article

References (40)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, CA Cancer J. Clin. 61 (2011) 69-90.
2. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, D.G. Coit, I.D. Fleming, J.E. Gershenwald, A. Houghton, J.M. Kirkwood, K.M. McMasters, M.F. Mihm, D.L. Morton, D.S. Reintgen, M.I. Ross, A. Sober, J.A. Thompson, J.F. Thompson, Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma, J. Clin. Oncol. 19 (2001) 3635-3648. (Pubitemid 32786276)
3. J. Bruix, J.M. Llovet, Prognostic prediction and treatment strategy in hepatocellu-lar carcinoma, Hepatology 35 (2002) 519-524. (Pubitemid 34183954)
4. S.J. Nelson, Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors, Magn. Reson. Med. 46 (2001) 228-239. (Pubitemid 32703267)
5. K. Nakanishi, M. Kobayashi, K. Nakaguchi, M. Kyakuno, N. Hashimoto, H. Onishi, N. Maeda, S. Nakata, M. Kuwabara, T. Murakami, H. Nakamura, Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images, Magn. Reson. Med. Sci. 6 (2007) 147-155.
6. P. Caravan, J.J. Ellison, T.J. McMurry, R.B. Lauffer, Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications, Chem. Rev. 99 (1999) 2293-2352. (Pubitemid 30498114)
7. M.F. Bellin, MR contrast agents, the old and the new, Eur. J. Radiol. 60 (2006) 314-323.
8. H.J. Weinmann, R.C. Brasch, W.R. Press, G.E. Wesbey, Characteristics of gadolinium-DTPA complex - a potential NMR contrast agent, Am. J. Roentgenol. 142 (1984) 619-624. (Pubitemid 14199123)
9. V. Comblin, D. Gilsoul, M. Hermann, V. Humblet, V. Jacques, M. Mesbahi, C. Sauvage, J.F. Desreux, Designing new MRI contrast agents: a coordination chemistry challenge, Coord. Chem. Rev. 185-6 (1999) 451-470.
10. M.W. Brechbiel, A.J.L. Villaraza, A. Bumb, Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics, Chem. Rev. 110 (2010) 2921-2959.
11. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release 65 (2000) 271-284. (Pubitemid 30122932)
12. A.L. Doiron, K. Chu, A. Ali, L. Brannon-Peppas, Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 17232-17237.
13. Z.R. Lu, D.L. Parker, K.C. Goodrich, X.H. Wang, J.G. Dalle, H.R. Buswell, Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI, Magn. Reson. Med. 51 (2004) 27-34. (Pubitemid 38095699)
14. H. Daldrup, D.M. Shames, M. Wendland, Y. Okuhata, T.M. Link, W. Rosenau, Y. Lu, R.C. Brasch, Correlation of dynamic contrast-enhanced MR imaging with histolog-ic tumor grade: comparison of macromolecular and small-molecular contrast media, Am. J. Roentgenol. 171 (1998) 941-949. (Pubitemid 28449949)
15. A. Gossmann, Y. Okuhata, D.M. Shames, T.H. Helbich, T.P.L. Roberts, M.F. Wendland, S. Huber, R.C. Brasch, Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macro-molecular and small-molecular contrast media - preliminary experience, Radiology 213 (1999) 265-272. (Pubitemid 29470436)
16. Y. Feng, E.K. Jeong, A.M. Mohs, L. Emerson, Z.-R. Lu, Characterization of tumor an-giogenesis with dynamic contrast-enhanced MRI and biodegradable macromo-lecular contrast agents in mice, Magn. Reson. Med. 60 (2008) 1347-1352.
17. A. Gossmann, T.H. Helbich, N. Kuriyama, S. Ostrowitzki, T.P.L. Roberts, D.M. Shames, N. van Bruggen, M.F. Wendland, M.A. Israel, R.C. Brasch, Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme, J. Magn. Reson. Imaging 15 (2002) 233-240. (Pubitemid 34195118)
18. C.D. Pham, T.P.L. Roberts, N. van Bruggen, O. Melnyk, J. Mann, N. Ferrara, R.L. Cohen, R.C. Brasch, Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor, Cancer Invest. 16 (1998) 225-230. (Pubitemid 28211008)
19. A. Tsourkas, Z.L. Cheng, D.L.J. Thorek, Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T(1) magnetic resonance imaging contrast agent, Angew. Chem. Int. Edit. 49 (2010) 346-350.
20. S.D. Konda, M. Aref, S. Wang, M. Brechbiel, E.C. Wiener, Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts, Magn. Reson. Math. Phys. Biol. Med. 12 (2001) 104-113. (Pubitemid 32510128)
21. E.C. Wiener, S. Konda, A. Shadron, M. Brechbiel, O. Gansow, Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor, Invest. Radiol. 32 (1997) 748-754. (Pubitemid 28053506)
22. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T.L. Haque, T. Ishimori, J. Konishi, K. Togashi, M.W. Brechbiel, Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer, Bioconjug. Chem. 12 (2001) 100-107. (Pubitemid 32111459)
23. R.Z. Xu, Y.L. Wang, X.L. Wang, E.K. Jeong, D.L. Parker, Z.R. Lu, In vivo evaluation of a PAMAM-Cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent, Exp. Biol. Med. 232 (2007) 1081-1089. (Pubitemid 47358191)
24. W.P. Cacheris, S.C. Quay, S.M. Rocklage, The relationship between thermodynamics and the toxicity of gadolium complexes, Magn. Reson. Imaging 8 (1990) 467-481. (Pubitemid 20321961)
25. A. Spencer, S. Wilson, E. Harpur, Gadolinium chloride toxicity in the mouse, Hum. Exp. Toxicol. 17 (1998) 633-637. (Pubitemid 28542579)
26. K. Nwe, M. Bernardo, C.A.S. Regino, M. Williams, M.W. Brechbiel, Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates, Bioorg. Med. Chem. 18 (2010) 5925-5931.
27. Y. Zong, X. Wang, E.-K. Jeong, D.L. Parker, Z.-R. Lu, Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents, Magn. Reson. Imaging 27 (2009) 503-511.
28. A.M. Mohs, X.H. Wang, K.C. Goodrich, Y.D. Zong, D.L. Parker, Z.R. Lu, PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging, Bioconjug. Chem. 15 (2004) 1424-1430. (Pubitemid 39552034)
29. X.H. Wang, Y. Feng, T.Y. Ke, M. Schabel, Z.R. Lu, Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent, Pharm. Res. 22 (2005) 596-602. (Pubitemid 40603257)
30. Y.Q. Shen, X.P. Ma, J.B. Tang, M.H. Fan, H.D. Tang, M. Radosz, Facile synthesis of polyester dendrimers from sequential click coupling of asymmetrical monomers, J. Am. Chem. Soc. 131 (2009) 14795-14803.
31. M. Ye, Y. Qian, Y. Shen, H. Hu, M. Sui, J. Tang, Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents, J. Mater. Chem. 22 (2012) 14369-14377.
32. J. Heyes, K. Hall, V. Tailor, R. Lenz, I. MacLachlan, Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery, J. Control. Release 112 (2006) 280-290.
33. T. Hirasawa, Y. Maeda, H. Kitano, Inclusional complexation by cyclodextrin-polymer conjugates in organic solvents, Macromolecules 31 (1998) 4480-4485. (Pubitemid 128567886)
34. G. Pasut, F. Canal, L.D. Via, S. Arpicco, F.A. Veronese, O. Schiavon, Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid, J. Control. Release 127 (2008) 239-248.
35. H. Rohwer, N. Collier, E. Hosten, Spectrophotometric study of arsenazo-III and its interactions with lanthanides, Anal. Chim. Acta 314 (1995) 219-223.
36. D.J. Parmelee, R.C. Walovitch, H.S. Ouellet, R.B. Lauffer, Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging, Invest. Radiol. 32 (1997) 741-747. (Pubitemid 28053505)
37. G.M. Nicolle, E. Toth, H. Schmitt-Willich, B. Raduchel, A.E. Merbach, The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent, Chem. Eur. J. 8 (2002) 1040-1048. (Pubitemid 34250981)
38. E. Toth, I. van Uffelen, L. Helm, A.E. Merbach, D. Ladd, K. Briley-Saebo, K.E. Kellar, Gadolinium-based linear polymer with temperature-independent proton relaxivities: a unique interplay between the water exchange and rotational contributions, Magn. Reson. Chem. 36 (1998) S125-S134.
39. D.M.J. Doble, M. Botta, J. Wang, S. Aime, A. Barge, K.N. Raymond, Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd-III complexes, J. Am. Chem. Soc. 123 (2001) 10758-10759. (Pubitemid 33015729)
40. C. Kojima, B. Turkbey, M. Ogawa, M. Bernardo, C.A.S. Regino, L.H. Bryant Jr., P.L. Choyke, K. Kono, H. Kobayashi, Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics, Nanomedicine Nanotechnol. 7 (2011) 1001-1008.